Hospital outbreak of a colistin-resistant, NDM-1- A nd OXA-48-producing klebsiella pneumoniae: High mortality from pandrug resistance

Microbial Drug Resistance

Volumn 24, Issue 7, 2018, Pages 966-972

  Guducuoglu, Huseyin ^a   Gursoy, Nafia Canan ^b   Yakupogullari, Yusuf ^b   Parlak, Mehmet ^a   Karasin, Gokhan ^a   Sunnetcioglu, Mahmut ^a   Otlu, Baris ^b  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

^b INONU UNIVERSITY   (Turkey)

Author keywords

carbapenem resistance; colistin; hospital outbreak; Klebsiella pneumoniae

Indexed keywords

CARBAPENEM; COLISTIN; IMIPENEM; MEROPENEM; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; BETA-LACTAMASE NDM-1; BETA-LACTAMASE OXA-48, E COLI; CARBAPENEM DERIVATIVE; CARBAPENEMASE; ESCHERICHIA COLI PROTEIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATION; CAUSE OF DEATH; CLINICAL ARTICLE; EPIDEMIC; FEMALE; GASTROINTESTINAL SURGERY; GENOTYPE; HUMAN; INFECTION CONTROL; INFECTIOUS COMPLICATION; INTRACRANIAL TUMOR; KLEBSIELLA PNEUMONIAE INFECTION; MALE; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; VERY ELDERLY; YOUNG ADULT; DRUG EFFECT; GENETICS; HOSPITAL; KLEBSIELLA INFECTION; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; NEWBORN; PLASMID; PROCEDURES;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; COLISTIN; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI PROTEINS; FEMALE; HOSPITALS; HUMANS; INFANT, NEWBORN; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; PLASMIDS; YOUNG ADULT;

EID: 85048179325     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2017.0173     Document Type: Article

References (35)

1. Podschun, R., U. Ullmann. 1998. Klebsiella spp. as nosocomial pathogens: Epidemiology, taxonomy, typing methods, pathogenicity factors. Clin. Microbiol. Rev. 11: 589-603.
2. Centers for Disease Control and Prevention (CDC). 2014. Antibiotic Resistance Threats in the United States (2013). Available at www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf#page=11 (accessed November 14, 2017).
3. Rupp, M.E., P.D. Fey. 2003. Extended spectrum b-lactamase (ESBL)-producing Enterobacteriaceae: Considerations for diagnosis, prevention and drug treatment. Drugs 63:353-365.
4. Yigit, H., A.M. Queenan, G.J. Anderson, A. Domenech-Sanchez, J.W. Biddle, C.D. Steward, S. Alberti, K. Bush, F.C. Tenover. 2001. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 45:1151-1161.
5. Antoniadou, A., F. Kontopidou, G. Poulakou, E. Koratzanis, I. Galani, E. Papadomichelakis, P. Kopterides, M. Souli, A. Armaganidis, H. Giamarellou. 2007. Colistinresistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: First report of a multiclonal cluster. J. Antimicrob. Chemother. 59:786-790.
6. Kontopoulou, K., E. Protonotariou, K. Vasilakos, M. Kriti, A. Koteli, E. Antoniadou, D. Sofianou. 2010. Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 beta-lactamase resistant to colistin. J. Hosp. Infect. 76:70-73.
7. Marchaim, D., T. Chopra, J.M. Pogue, F. Perez, A.M. Hujer, S. Rudin, A. Endimiani, S. Navon-Venezia, J. Hothi, J. Slim, C. Blunden, M. Shango, P.R. Lephart, H. Salimnia, D. Reid, J. Moshos, W. Hafeez, S. Bheemreddy, T.Y. Chen, S. Dhar, R.A. Bonomo, K.S. Kaye. 2011. Outbreak of colistin-resistant, carbapenem-resistant Klebsiella pneumoniae in metropolitan Detroit, Michigan. Antimicrob. Agents Chemother. 55:593-599.
8. The European Committee on Antimicrobial Susceptibility (EUCAST). 2015. Testing breakpoint tables for interpretation of MICs and zone diameters. Version 7.1. Available at www.eucast.org/clinical-breakpoints (accessed November 14, 2017).
9. Monteiro, J., R.H. Widen, A.C. Pignatari, C. Kubasek, S. Silbert. 2012. Rapid detection of carbapenemase genes by multiplex real-time PCR. J. Antimicrob. Chemother. 67: 906-909.
10. Ellington, M.J., J. Kistler, D.M. Livermore, N.Woodford. 2007. Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases. J. Antimicrob. Chemother. 59:321-322.
11. Liu, Y.Y., Y. Wang, T.R. Walsh, L.X. Yi, R. Zhang, J. Spencer, Y. Doi, G. Tian, B. Dong, X. Huang, L.F. Yu, D. Gu, H. Ren, X. Chen, L. Lv, D. He, H. Zhou, Z. Liang, J.H. Liu, J. Shen. 2016. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: A microbiological and molecular biological study. Lancet Infect. Dis. 16:161-168.
12. Xavier, B.B., C. Lammens, R. Ruhal, S. Kumar-Singh, P. Butaye, H. Goossens, S. Malhotra-Kumar. 2016. Identification of a novel plasmid-mediated colistin-resistance gene, mcr-2, in Escherichia coli, Belgium, June 2016. Euro. Surveill. 21:27.
13. Yin, W., H. Li, Y. Shen, Z. Liu, S.Wang, Z. Shen, R. Zhang, T.R. Walsh, J. Shen, W. Yang. 2017. Novel plasmidmediated colistin resistance gene mcr-3 in Escherichia coli. mBio 8:e00543-17.
14. Durmaz, R., B. Otlu, F. Koksal, S. Hosoglu, R. Ozturk, Y. Ersoy, E. Aktas, N.C. Gursoy, A. Caliskan. 2009. The optimization of a rapid pulsed-field gel electrophoresis protocol for the typing of Acinetobacter baumannii, Escherichia coli and Klebsiella spp. Jpn. J. Infect. Dis. 62: 372-377.
15. Diancourt, L., V. Passet, J. Verhoef, P.A. Grimont, S. Brisse. 2005. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J. Clin. Microbiol. 43: 4178-4182.
16. World Health Organization (WHO). 2015. Healthcareassociated infections Fact sheet. Available at www.who.int/gpsc/country-work/gpsc-ccisc-fact-sheet-en.pdf (accessed November 14, 2017).
17. Deptua, A., E. Trejnowska, G. Dubiel, M. Z-ukowski, A. Misiewska-Kaczur, T. Ozorowski, W. Hryniewicz. 2017. Prevalence of healthcare-associated infections in Polish adult intensive care units: Summary data from the ECDC European Point Prevalence Survey of Hospital-Associated Infections and Antimicrobial Use in Poland 2012-2014. J. Hosp. Infect. 96:145-150.
18. Erdem, H., A. Inan, S. Altndis, B. Carevic, M. Askarian, L. Cottle, B. Beovic, A. Csomos, K. Metodiev, S. Ahmetagic, A. Harxhi, L. Raka, K. Grozdanovski, M. Nechifor, E. Alp, F. Bozkurt, S. Hosoglu, I. Balik, G. Yilmaz, M. Jereb, F. Moradi, N. Petrov, S. Kaya, I. Koksal, T. Aslan, N. Elaldi, Y. Akkoyunlu, S.A. Moravveji, G. Csato, B. Szedlak, F. Akata, S. Oncu, S. Grgic, G. Cosic, C. Stefanov, M. Farrokhnia, M. Müller, C. Luca, N. Koluder, V. Korten, V. Platikanov, P. Ivanova, S. Soltanipour, M. Vakili, S. Farahangiz, A. Afkhamzadeh, N. Beeching, S.S. Ahmed, A. Cami, R. Shiraly, A. Jazbec, T. Mirkovic, H. Leblebicioglu, K. Naber. 2014. Surveillance, control and management of infections in intensive care units in Southern Europe, Turkey and Iran-a prospective multicenter point prevalence study. J. Infect. 68:131-140.
19. Zarb, P., B. Coignard, J. Griskeviciene, A. Muller, V. Vankerckhoven, K. Weist, M. Goossens, S. Vaerenberg, S. Hopkins, B. Catry, D. Monnet, H. Goossens, C. Suetens. 2012. The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcareassociated infections and antimicrobial use. Euro. Surveill. 17:46.
20. Albiger, B., C. Glasner, M.J. Struelens, H. Grundmann, D.L. Monnet. 2015. Carbapenemase-producing Enterobacteriaceae in Europe: Assessment by national experts from 38 countries, May 2015. Euro. Surveill. 20:45.
21. De Laveleye, M., T.D. Huang, P. Bogaerts, C. Berhin, C. Bauraing, P. Sacré, A. Noel, Y. Glupczynski. 2017. Increasing incidence of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in Belgian hospitals. Eur. J. Clin. Microbiol. Infect. Dis. 36:139-146.
22. Meatherall, B.L., D. Gregson, T. Ross, J.D. Pitout, K.B. Laupland. 2009. Incidence, risk factors, outcomes of Klebsiella pneumoniae bacteremia. Am. J. Med. 122:866-873.
23. Voulgari, E., O. Zarkotou, K. Ranellou, D.E. Karageorgopoulos, G. Vrioni, V. Mamali, K. Themeli-Digalaki, A. Tsakris. 2013. Outbreak of OXA-48 carbapenemaseproducing Klebsiella pneumoniae in Greece involving an ST11 clone. J. Antimicrob. Chemother. 68:84-88.
24. Ma, L., J.T. Wang, T.L. Wu, L.K. Siu, Y.C. Chuang, J.C. Lin, M.C. Lu, P.L. Lu. 2015. Emergence of OXA-48-producing Klebsiella pneumoniae in Taiwan. PLoS ONE 10:e0139152.
25. Halaby, T., E. Kucukkose, A.B. Janssen, M.R. Rogers, D.J. Doorduijn, A.G. van der Zanden, N. Al Naiemi, C.M. Vandenbroucke-Grauls, W. van Schaik. 2016. Genomic characterization of colistin heteroresistance in Klebsiella pneumoniae during a nosocomial outbreak. Antimicrob. Agents Chemother. 60:6837-6843.
26. Halaby, T., N. Al Naiemi, J. Kluytmans, J. van der Palen, C.M. Vandenbroucke-Grauls. 2013. Emergence of colistin resistance in Enterobacteriaceae after the introduction of selective digestive tract decontamination in an intensive care unit. Antimicrob. Agents Chemother. 57:3224-3229.
27. Lee, C.R., J.H. Lee, K.S. Park, Y.B. Kim, B.C. Jeong, S.H. Lee. 2016. Global dissemination of carbapenemaseproducing Klebsiella pneumoniae: Epidemiology, genetic context, treatment options, detection methods. Front. Microbiol. 7:895.
28. Baran, I., N. Aksu. 2016. Phenotypic and genotypic characteristics of carbapenem-resistant Enterobacteriaceae in a tertiary-level reference hospital in Turkey. Ann. Clin. Microbiol. Antimicrob. 15:20.
29. Kilic, A., M. Baysallar. 2015. The first Klebsiella pneumoniae isolate co-producing OXA-48 and NDM-1 in Turkey. Ann. Lab. Med. 35:382-383.
30. Karlowsky, J.A., S.H. Lob, K.M. Kazmierczak, R.E. Badal, K. Young, M.R. Motyl, D.F. Sahm. 2017. In vitro activity of imipenem against carbapenemase-positive Enterobacteriaceae: SMART global surveillance program 2008-2014. J. Clin. Microbiol. 55:1638-1649.
31. Falagas, M.E., P. Rafailidis, D.K. Matthaiou. 2010. Resistance to polymyxins: Mechanisms, frequency and treatment options. Drug Resist. Updat. 13:132-138.
32. Giani, T., F. Arena, G. Vaggelli, V. Conte, A. Chiarelli, L. Henrici De Angelis, R. Fornaini, M. Grazzini, F. Niccolini, P. Pecile, G.M. Rossolini. 2015. Large nosocomial outbreak of colistin-resistant, carbapenemase-producing Klebsiella pneumoniae traced to clonal expansion of an mgrB deletion mutant. J. Clin. Microbiol. 53:3341-3344.
33. Ah, Y.M., A.J. Kim, J.Y. Lee. 2014. Colistin resistance in Klebsiella pneumoniae. Int. J. Antimicrob. Agents 44:8-15.
34. European Centre for Disease Prevention and Control (ECDC). 2016. Last-line antibiotics are failing: Options to address this urgent threat to patients and healthcare systems. Available at http://ecdc.europa.eu/en/publications/Publications/antibiotic-resistance-policy-briefing.pdf (accessed November 14, 2017).
35. Andrade, L.N., L. Vitali, G.G. Gaspar. 2014. Expansion and evolution of a virulent, extensively drug-resistant (polymyxin B-resistant), QnrS1-, CTX-M-2-, KPC-2-producing Klebsiella pneumoniae ST11 international highrisk clone. J. Clin. Microbiol. 52:2530-2535.